Is VUG a Good ETF to Buy?
For the last few years, earnings growth from the tech…
Sell
31
XYL Quote, Financials, Valuation and Earnings
Last price:
$122.87
Seasonality move
:
1.93%
Day range:
$123.49 - $128.16
52-week range:
$113.26 - $146.08
Dividend yield:
1.2%
P/E ratio:
33.87x
P/S ratio:
3.52x
P/B ratio:
2.82x
Volume:
1.9M
Avg. volume:
1.5M
1-year change:
-2.02%
Market cap:
$30B
Revenue:
$8.6B
EPS (TTM):
$3.65
Analysts' Opinion
-
Consensus RatingXylem has received a consensus rating of Buy. The company's average rating is a Buy based on 9 Buy ratings, 8 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $146.13, Xylem has an estimated upside of 18.01% from its current price of $123.63.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $114.15 representing 7.67% downside risk from its current price of $123.63.
Fair Value
-
According to the consensus of 17 analysts, Xylem has 18.01% upside to fair value with a price target of $146.13 per share.
XYL vs. S&P 500
-
Over the past 5 trading days, Xylem has overperformed the S&P 500 by 0% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Xylem does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Xylem has grown year-over-year revenues for 12 quarters straight. In the most recent quarter Xylem reported revenues of $2.3B.
Earnings Growth
-
Xylem has grown year-over-year earnings for 6 quarters straight. In the most recent quarter Xylem reported earnings per share of $1.33.
Enterprise value:
31.2B
EV / Invested capital:
2.42x
Price / LTM sales:
3.52x
EV / EBIT:
27.57x
EV / Revenue:
3.64x
PEG ratio (5yr expected):
1.08x
EV / Free cash flow:
33.10x
Price / Operating cash flow:
31.96x
Enterprise value / EBITDA:
18.42x
Gross Profit (TTM):
$3.2B
Return On Assets:
5.54%
Net Income Margin (TTM):
10.4%
Return On Equity:
8.52%
Return On Invested Capital:
7.09%
Operating Margin:
12.94%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $5.5B | $7.4B | $8.6B | $2.1B | $2.3B | |
| Gross Profit | $2.1B | $2.7B | $3.2B | $756M | $857M | |
| Operating Income | $511M | $728M | $1.1B | $230M | $292M | |
| EBITDA | $726M | $1.1B | $1.7B | $361M | $526M | |
| Diluted EPS | $1.96 | $2.78 | $3.65 | $1.16 | $1.33 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3.5B | $3.2B | $3B | $3.9B | $4.1B | |
| Total Assets | $8.8B | $8.3B | $8B | $16.1B | $16.5B | |
| Current Liabilities | $2B | $1.4B | $1.6B | $2.2B | $2.3B | |
| Total Liabilities | $5.8B | $5.1B | $4.4B | $5.9B | $5.6B | |
| Total Equity | $3B | $3.2B | $3.5B | $10.2B | $10.9B | |
| Total Debt | $3.1B | $2.4B | $1.9B | $2.3B | $2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $596M | $837M | $1.3B | $455M | $575M | |
| Cash From Investing | -$191M | -$628M | -$482M | -$89M | -$289M | |
| Cash From Financing | -$790M | -$157M | -$615M | -$86M | -$95M | |
| Free Cash Flow | $388M | $566M | $942M | $361M | $475M | |
XYL
Sector
Market Cap
$30B
$602.8M
Price % of 52-Week High
84.63%
73.55%
Dividend Yield
1.2%
0%
Shareholder Yield
1.49%
2.63%
1-Year Price Total Return
-2.02%
-7.02%
Beta (5-Year)
1.084
0.892
Dividend yield:
1.2%
Annualized payout:
$1.44
Payout ratio:
39.33%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$128.71
200-day SMA
Sell
Level
$130.27
Bollinger Bands (100)
Sell
Level
119.21 - 130.73
Chaikin Money Flow
Buy
Level
142.2M
20-day SMA
Sell
Level
$129.44
Relative Strength Index (RSI14)
Sell
Level
40.34
ADX Line
Sell
Level
28.77
Williams %R
Buy
Level
-98.4799
50-day SMA
Sell
Level
$123.70
MACD (12, 26)
Buy
Level
0.80
25-day Aroon Oscillator
Sell
Level
-76
On Balance Volume
Neutral
Level
67M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.1549)
Buy
CA Score
(Annual)
Level (0.688)
Buy
Beneish M-Score
(Annual)
Level (-2.5457)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-2.3801)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $8.6 billion in revenue in 2024.
Stock Forecast FAQ
In the current month, XYL has received 9 Buy ratings 8 Hold ratings, and 0 Sell ratings. The XYL average analyst price target in the past 3 months is $146.13.
-
Where Will Xylem Stock Be In 1 Year?
According to analysts, the consensus estimate is that Xylem share price will rise to $146.13 per share over the next 12 months.
-
What Do Analysts Say About Xylem?
Analysts are divided on their view about Xylem share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Xylem is a Sell and believe this share price will drop from its current level to $114.15.
-
What Is Xylem's Price Target?
The price target for Xylem over the next 1-year time period is forecast to be $146.13 according to 17 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 8 analysts rate the stock a Hold.
-
Is XYL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Xylem is a Buy. 9 of 17 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of XYL?
You can purchase shares of Xylem via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Xylem shares.
-
What Is The Xylem Share Price Today?
Xylem was last trading at $122.87 per share. This represents the most recent stock quote for Xylem. Yesterday, Xylem closed at $123.63 per share.
-
How To Buy Xylem Stock Online?
In order to purchase Xylem stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Does Intel Stock Have Room to Grow?
Intel Corporation (NASDAQ:INTC)’s recent innovations, Xeon 6 SoC and Xeon®…
Is Walmart the Largest Retailer in the World?
For many years, Walmart (NYSE:WMT) has been the world’s largest…
Stock Ideas
Sell
49
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
44
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
45
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Sell
50
GH alert for Mar 12
Guardant Health [GH] is up 1.1% over the past day.
Sell
44
TER alert for Mar 12
Teradyne [TER] is down 0.36% over the past day.
Buy
57
LMB alert for Mar 12
Limbach Holdings [LMB] is down 4.39% over the past day.
